Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis von Azuri, Joseph, Hammerman, Ariel, Aboalhasan, Enis, Sluckis, Ben, Arbel, Ronen

Volltext

The impact of digitisation of a virtual fracture clinic on referral quality, outcomes and assessment times von Sephton, Benjamin M., Morley, Hannah, Mahapatra, Piyush, Shenouda, Michael, Al-Yaseen, Mustafa, Bernstein, Darryl E., Cross, George, Dalili, Daniel E., Gurung, Amrit, Kamat, Atul, Kuc, Andrew J., Mohammed, Aisha R., Paraouty, Mehreen, Ponniah, Amsanaa, Sluckis, Ben, Deierl, Krisztian

Volltext

Liraglutide versus semaglutide for weight reduction—a cost needed to treat analysis von Azuri, Joseph, Hammerman, Ariel, Aboalhasan, Enis, Sluckis, Ben, Arbel, Ronen

Volltext

Abstract 13465: Tirzepatide vs. Semaglutide for Secondary Prevention of Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes Mellitus With an Initial HbA1c of >8.5... von Azuri, Joseph, Aboalhasan, Enis, Sluckis, Ben, Hammerman, Ariel, Arbel, Ronen

Volltext

Abstract 13050: Tirzepatide versus Semaglutide for Secondary Prevention of Major Adverse Cardiovascular Events in Patients Over the Age of 65 With Type 2 Diabetes Mellitus-Value pe... von Arbel, Ronen, Hammerman, Ariel, Aboalhasan, Enis, Sluckis, Ben, Azuri, Joseph

Volltext

Abstract 15300: Tirzepatide vs. Semaglutide for Weight Loss in Patients With Type 2 Diabetes Mellitus - A Value for Money Analysis von Azuri, Joseph, Hammerman, Ariel, Aboalhasan, Enis, Sluckis, Ben, Arbel, Ronen

Volltext

Can a selective policy after primary chemotherapy (PC) reduce the need for full dissection of the initially positive axilla? von Sluckis, Ben, McDonnell, Juan, Imtiaz-Crosbie, Fawzia, Jaffe, Victor

Volltext